MA04.02 Neratinib ± Temsirolimus in HER2-Mutant Lung Cancers: An International, Randomized Phase II Study

Authors

Keywords

Journal

Volume 12, Issue 1, Pages S358-S359

Publisher

Elsevier BV

Online

2017-01-04

DOI

10.1016/j.jtho.2016.11.398

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now